Translational Drug Development (TD2)
Adeline Chin currently serves as a Clinical Data Associate at Translational Drug Development (TD2) since November 2022 and has held the role of Instructor at Eastside Technology Center since December 2021. Prior experience includes working as a Clinical Research Assistant II at Eastside Research Associates, as well as positions as an Instructor at Mathnasium and a Team Leader at Jumpstart. Additional roles include Clinical Research Data Assistant at Seattle Children's and Sales Associate at Madewell. Adeline began professional experience as a Substitute Teacher at Pike Market Child Care Center and a Teacher Aide at Country Village Day School. Adeline holds a Bachelor's degree in Mathematics and a Bachelor's degree in Spanish Language and Literature from the University of Washington, and is currently pursuing a Master's degree in Information, Data Science at the University of California, Berkeley, expected to complete in August 2024.
This person is not in the org chart
This person is not in any offices
Translational Drug Development (TD2)
Translational Drug Development (TD2) is an oncology-focused Contract Research Organization (CRO) that supports improved and accelerated development of medicines for life-threatening diseases. We help companies move their drugs through the critical stages of preclinical, regulatory and clinical trial processes. Our scientific depth, proactive problem solving, and strategic direction and advice increase the likelihood of positive outcomes that bring hope and a better quality of life to cancer patients and their families. TD2 was born from the Translational Genomics Research Institute (TGen) as a nonprofit in 2003. TGen’s deep scientific expertise and approach to interrogating the “omic” drivers of disease is at the heart of TD2’s heritage and has become the foundation upon which TD2 creates unique clinical strategies for its clients.